{"id":7846,"date":"2018-03-07T11:51:13","date_gmt":"2018-03-07T11:51:13","guid":{"rendered":"https:\/\/jurmed.ro\/medici\/?p=7846"},"modified":"2018-03-07T11:51:13","modified_gmt":"2018-03-07T11:51:13","slug":"un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor","status":"publish","type":"post","link":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/","title":{"rendered":"Un nou medicament pentru tratamentul hemofiliei A cu inhibitor"},"content":{"rendered":"<p style=\"text-align: justify\"><strong>Comisia European\u0103 a aprobat u<\/strong><strong>n nou medicament produs de Roche, pentru tratamentul hemofiliei A cu inhibitor<\/strong><\/p>\n<ul style=\"text-align: justify\">\n<li><strong>Primul medicament nou aprobat din ultimii 10 ani \u00een Europa pentru <\/strong><strong>pentru tratamentul pacien\u0163ilor cu hemofilie A care prezint\u0103 inhibitor de factor VIII<\/strong><\/li>\n<li><strong>Administrarea subcutanat\u0103 s\u0103pt\u0103m\u00e2nal\u0103 poate reduce povara tratamentului<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify\"><a href=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofiliea.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-7848\" src=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofiliea-290x300.jpg\" alt=\"\" width=\"290\" height=\"300\" srcset=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofiliea-290x300.jpg 290w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofiliea.jpg 549w\" sizes=\"auto, (max-width: 290px) 100vw, 290px\" \/><\/a>Comisia European\u0103 a aprobat un nou medicament Roche destinat profilaxiei de rutin\u0103 a episoadelor de s\u00e2ngerare, la persoanele care sufer\u0103 de hemofilie A care prezint\u0103 inhibitor de factor VIII. Acest medicament poate fi utilizat de c\u0103tre to\u021bi pacien\u021bii, indiferent de v\u00e2rst\u0103. Aproape una din trei persoane care sufer\u0103 de forme severe ale hemofiliei A poate dezvolta inhibitor la terapia cu \u00eenlocuitor de factor VIII, ceea ce cre\u0219te riscul unor s\u00e2nger\u0103ri. Aceste s\u00e2nger\u0103ri fie pot pune via\u021ba \u00een pericol, fie pot cauza probleme pe termen lung, prin afectarea articula\u021biilor<a href=\"#_ftn1\" name=\"_ftnref1\">[1]<\/a>. Persoanele care sufer\u0103 de hemofilie A cu inhibitor al factorului VIII prezint\u0103 un risc de deces cu 70% mai mare, comparativ cu cei care sufer\u0103 de forma bolii f\u0103r\u0103 inhibitor<a href=\"#_ftn2\" name=\"_ftnref2\">[2]<\/a>.<\/p>\n<p style=\"text-align: justify\"><em>\u201e<\/em><em>Aceast\u0103 aprobare este o veste foarte bun\u0103 pentru <\/em><em>pacien\u021bii europeni care sufer<\/em><em>\u0103<\/em><em>de hemofilie A cu inhibitor alfactorului VIII.\u00a0 Apari\u021bia \u00een timp a acestor inhibitori <\/em><em>nu doar cre<\/em><em>\u0219<\/em><em>te riscul unor episoade de s\u00e2nger\u0103ri mai dese <\/em><em>\u0219i mai grave ci \u00een plus <\/em><em>face <\/em><em>\u0219<\/em><em>i mult mai dificil\u0103 gestionarea boli<\/em><em>i<\/em><em>, av\u00e2nd \u00een vedere op<\/em><em>\u021b<\/em><em>iunile terapeutice limitate de p\u00e2n\u0103 acum,\u201d<\/em> a afirmat Profesorul Johannes Oldenburg, Institute of Experimental Haematology and Transfusion Medicine, Universitatea din Bonn, Germania.<em>\u201e<\/em><em>Reducerea s\u00e2nger\u0103rilor <\/em><em>\u0219<\/em><em>i \u00eembun\u0103t\u0103<\/em><em>\u021b<\/em><em>irea calit\u0103<\/em><em>\u021b<\/em><em>ii vie<\/em><em>\u021b<\/em><em>ii <\/em><em>ap<\/em><em>\u0103<\/em><em>rute \u00een urma tratamentului cu acest nou <\/em><em>medicament, arat\u0103 poten<\/em><em>\u021b<\/em><em>ialul acestui <\/em><em>produs de<\/em><em> a \u00eembun\u0103t\u0103\u0163i <\/em><em>modul \u00een care este gestionat<\/em><em>\u0103\u00a0<\/em><em>hemofilia A cu inhibitor.\u201d<\/em><\/p>\n<p style=\"text-align: justify\"><em>\u201eSuntem \u00ee<\/em><em>nc\u00e2nta\u0163i\u00a0<\/em><em>s<\/em><em>\u0103<\/em><em> primim aprobarea Comisiei Europene pentru acest medicament, care ofer<\/em><em>\u0103<\/em><em> persoanelor cu hemofilie A cu inhibitor o nou<\/em><em>\u0103<\/em><em> op\u021biune terapeutic<\/em><em>\u0103<\/em><em>,\u00a0 prima \u00een ultimii 20 de ani\u201d,<\/em> a afirmat Sandra Horning, Chief Medical Officer \u0219i Head of Global Product Development al grupului Roche. \u201d<em>Noi credem c\u0103 acest medicament are poten<\/em><em>\u021b<\/em><em>ialul de a face o diferen<\/em><em>\u021b<\/em><em>\u0103 semnificativ\u0103 \u00een vie<\/em><em>\u021b<\/em><em>ile persoanelor cu hemofilie A cu inhibitor<\/em><em> \u0219i <\/em><em>ne exprim\u0103<\/em><em>m disponibilitatea de a lucra<\/em><em> \u00eempreun\u0103 cu statele membre UE\u00een vederea asigur\u0103rii accesului c\u00e2t mai rapid la acest medicament important<\/em><em>.\u201d<\/em><\/p>\n<p style=\"text-align: justify\">Comisia European\u0103 a aprobat acest medicament pe baza a dou\u0103 dintre cele mai mari studii clinice, \u00een care acest produs a demonstrat eficien\u021b\u0103 superioar\u0103 comparativ cu tratamentele anterioare cu agen\u021bi de bypass, administra\u021bi \u00een profilaxie sau la cerere. Medicamentul a fost deja aprobat \u00een Statele Unite ale Americii de c\u0103tre U.S. Food and Drug Administration (FDA) la finalul anului trecut.<\/p>\n<p style=\"text-align: justify\">Hemofilia este o boal\u0103 ereditar\u0103 grav\u0103 a s\u00e2ngelui, care face ca s\u00e2ngele unei persoane s\u0103 nu se coaguleze corect, duc\u00e2nd la s\u00e2nger\u0103ri necontrolabile, care pot avea loc spontan sau \u00een urma unor traumatisme minore. Statisticile arata c\u0103, la nivel global, peste 320.000 de persoane tr\u0103iesc cu hemofilie de tip A, cea mai des \u00eent\u00e2lnit\u0103 form\u0103 a bolii. Persoanele cu hemofilie A nu au suficient sau deloc factorul de coagulare numit factorul VIII. Lipsa acestui factor \u00eempiedic\u0103 coagularea normal\u0103 a s\u00e2ngelui. La o persoan\u0103 s\u0103n\u0103toas\u0103, proteinele numite factori de coagulare lucreaz\u0103 \u00eempreun\u0103 pentru a forma un cheag de s\u00e2nge \u0219i a opri s\u00e2ngerarea.<\/p>\n<p style=\"text-align: justify\">\n<p style=\"text-align: justify\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: justify\"><a href=\"#_ftnref1\" name=\"_ftn1\">[1]<\/a>European Haemophilia Consortium [Internet; cited 2018 January]. Available from: https:\/\/www.ehc.eu\/bleeding-disorders\/inhibitors\/<\/p>\n<p style=\"text-align: justify\"><a href=\"#_ftnref2\" name=\"_ftn2\">[2]<\/a>www.cdc.gov\/ncbddd\/hemophilia\/features\/inhibitor-severe-hemophilia-a.html<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Comisia European\u0103 a aprobat un nou medicament produs de Roche, pentru tratamentul hemofiliei A cu inhibitor Primul medicament nou aprobat din ultimii 10 ani \u00een Europa pentru pentru tratamentul pacien\u0163ilor [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":7847,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7846","post","type-post","status-publish","format-standard","has-post-thumbnail","category-stiri-noutati"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un nou medicament pentru tratamentul hemofiliei A cu inhibitor<\/title>\n<meta name=\"description\" content=\"Comisia European\u0103 a aprobat un nou medicament produs de Roche, pentru tratamentul hemofiliei A cu inhibitor\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un nou medicament pentru tratamentul hemofiliei A cu inhibitor\" \/>\n<meta property=\"og:description\" content=\"Comisia European\u0103 a aprobat un nou medicament produs de Roche, pentru tratamentul hemofiliei A cu inhibitor\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/\" \/>\n<meta property=\"og:site_name\" content=\"Jurmed - Medici\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-07T11:51:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofilie.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"306\" \/>\n\t<meta property=\"og:image:height\" content=\"295\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ralucab\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"ralucab\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/\"},\"author\":{\"name\":\"ralucab\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35\"},\"headline\":\"Un nou medicament pentru tratamentul hemofiliei A cu inhibitor\",\"datePublished\":\"2018-03-07T11:51:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/\"},\"wordCount\":605,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofilie.jpg\",\"articleSection\":[\"Stiri \/ Noutati\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/\",\"url\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/\",\"name\":\"Un nou medicament pentru tratamentul hemofiliei A cu inhibitor\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofilie.jpg\",\"datePublished\":\"2018-03-07T11:51:13+00:00\",\"author\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35\"},\"description\":\"Comisia European\u0103 a aprobat un nou medicament produs de Roche, pentru tratamentul hemofiliei A cu inhibitor\",\"breadcrumb\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#primaryimage\",\"url\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofilie.jpg\",\"contentUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofilie.jpg\",\"width\":306,\"height\":295},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jurmed.ro\/medici\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un nou medicament pentru tratamentul hemofiliei A cu inhibitor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\",\"url\":\"https:\/\/jurmed.ro\/medici\/\",\"name\":\"Jurmed - Medici\",\"description\":\"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jurmed.ro\/medici\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35\",\"name\":\"ralucab\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g\",\"caption\":\"ralucab\"},\"url\":\"https:\/\/jurmed.ro\/medici\/author\/ralucabocancia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un nou medicament pentru tratamentul hemofiliei A cu inhibitor","description":"Comisia European\u0103 a aprobat un nou medicament produs de Roche, pentru tratamentul hemofiliei A cu inhibitor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/","og_locale":"ro_RO","og_type":"article","og_title":"Un nou medicament pentru tratamentul hemofiliei A cu inhibitor","og_description":"Comisia European\u0103 a aprobat un nou medicament produs de Roche, pentru tratamentul hemofiliei A cu inhibitor","og_url":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/","og_site_name":"Jurmed - Medici","article_published_time":"2018-03-07T11:51:13+00:00","og_image":[{"width":306,"height":295,"url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofilie.jpg","type":"image\/jpeg"}],"author":"ralucab","twitter_misc":{"Scris de":"ralucab","Timp estimat pentru citire":"3 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#article","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/"},"author":{"name":"ralucab","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35"},"headline":"Un nou medicament pentru tratamentul hemofiliei A cu inhibitor","datePublished":"2018-03-07T11:51:13+00:00","mainEntityOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/"},"wordCount":605,"commentCount":0,"image":{"@id":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofilie.jpg","articleSection":["Stiri \/ Noutati"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/","url":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/","name":"Un nou medicament pentru tratamentul hemofiliei A cu inhibitor","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#primaryimage"},"image":{"@id":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofilie.jpg","datePublished":"2018-03-07T11:51:13+00:00","author":{"@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35"},"description":"Comisia European\u0103 a aprobat un nou medicament produs de Roche, pentru tratamentul hemofiliei A cu inhibitor","breadcrumb":{"@id":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#primaryimage","url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofilie.jpg","contentUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2018\/03\/hemofilie.jpg","width":306,"height":295},{"@type":"BreadcrumbList","@id":"https:\/\/jurmed.ro\/medici\/un-nou-medicament-pentru-tratamentul-hemofiliei-cu-inhibitor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jurmed.ro\/medici\/"},{"@type":"ListItem","position":2,"name":"Un nou medicament pentru tratamentul hemofiliei A cu inhibitor"}]},{"@type":"WebSite","@id":"https:\/\/jurmed.ro\/medici\/#website","url":"https:\/\/jurmed.ro\/medici\/","name":"Jurmed - Medici","description":"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jurmed.ro\/medici\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Person","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35","name":"ralucab","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g","caption":"ralucab"},"url":"https:\/\/jurmed.ro\/medici\/author\/ralucabocancia\/"}]}},"_links":{"self":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/7846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/comments?post=7846"}],"version-history":[{"count":1,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/7846\/revisions"}],"predecessor-version":[{"id":7849,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/7846\/revisions\/7849"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media\/7847"}],"wp:attachment":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media?parent=7846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/categories?post=7846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tags?post=7846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}